# Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement

> **NCT01531374** · NA · COMPLETED · sponsor: **Medtronic Cardiovascular** · enrollment: 2777 (actual)

## Conditions studied

- Severe Aortic Stenosis

## Interventions

- **DEVICE:** Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)

## Key facts

- **NCT ID:** NCT01531374
- **Lead sponsor:** Medtronic Cardiovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-21
- **Primary completion:** 2015-11
- **Final completion:** 2019-11-18
- **Target enrollment:** 2777 (ACTUAL)
- **Last updated:** 2022-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01531374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01531374, "Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01531374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*